Developer docs
API playgroundTry for free, no card

Search company profiles

Pramana

Full company profile

uuid0000bw4

Namestring
Pramana
Legal namestring
Pramana, Inc.
Websiteurl
pramana.ai
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Pramana, Inc. is a Cambridge, Massachusetts-based medical technology company that designs and manufactures autonomous whole slide imaging (WSI) systems for digital pathology. Founded in 2021 as a spin-off from healthcare AI company nference, Pramana serves hospital pathology departments, research facilities, and educational institutions seeking to digitize and automate slide scanning workflows. The company has a workforce of 101–250 employees and operates as a wholly-owned subsidiary of Evident (the scientific imaging business spun off from Olympus Corporation in 2022) following its acquisition in August 2025.

Pramana's core product line is the Spectral family of scanners, which includes the high-throughput SpectralHT (available in 2-Head and 4-Head configurations supporting up to 960 slides), the compact SpectralM (supporting 2–4 slides per load), and the modular SpectralHT Cubiq. The systems are differentiated by hardware-software co-design, proprietary volumetric imaging that replicates optical microscope fine-focus through Z-stack fusion, and edge AI capable of executing multiple feature description algorithms in real time during scanning. The company holds four granted US patents and one pending application covering slide imaging, hot-swapping components, color gamut normalization, and inline image scan enrichment. Regulatory clearances include CE, EU IVDR, ISO 13485, and Health Canada Medical Device Licenses (granted July 2025); in the US, products are currently marketed for research use only.

Pramana generates revenue primarily through hardware sales of its integrated scanner systems, sold via enterprise field sales directly to healthcare and research customers. Named customers include Mayo Clinic, Duke, Moffitt Cancer Center, Caris Life Sciences, Iron Mountain, Arup, PRISMIC, and Splice Histology. Post-acquisition, distribution is augmented by Evident's global scientific imaging network. The company has established interoperability partnerships with image management system vendors including Proscia, GSTALT, pathPresenter, Techcyte, and Corista, and in September 2025 entered a strategic collaboration with Siemens Healthineers to advance digital pathology at Klinikum Ludwigshafen in Germany.

Short descriptiontext

Pramana, Inc. manufactures autonomous whole slide imaging scanners (SpectralHT, SpectralM) for digital pathology, serving hospitals, research facilities, and educational institutions. Founded in 2021 and acquired by Evident in 2025, the company operates from Cambridge, MA with proprietary volumetric imaging and edge AI capabilities.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology scanners, whole slide imaging, autonomous microscopy systems, pathology imaging hardware, clinical diagnostics equipment
Industry2 codes
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Optical Instruments & Lenses3827
Product category
Digital Pathology Imaging Systems
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Whole Slide Imaging Systems
TypeHardware Sales
Description

Sale of autonomous whole slide imaging systems (SpectralHT, SpectralM) to hospitals, research facilities, and educational institutions. Hardware-software integrated solutions with modular configurations.

financialpost.com
2AI-Powered Scanning Technologies
TypeHardware Sales
Description

Sale of AI-powered scanning technologies and digital pathology solutions, including real-time feature detection and classification algorithms

pramana.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pramana designs, manufactures, and sells autonomous whole slide imaging (WSI) scanners for digital pathology applications. Its Spectral family of scanners uses proprietary volumetric imaging and real-time edge AI to scan pathology slides without manual intervention, supporting clinical diagnostics, research, and educational use at hospitals, research facilities, and academic institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 70% reduction in manual workflow steps
+3 more records
Product overview1 text field

Pramana offers a portfolio of autonomous whole slide imaging systems for digital pathology under the Spectral family brand. The product line includes the SpectralHT (available in 2-Head and 4-Head configurations) for high-throughput laboratory needs, and the SpectralM for compact deployments. All systems feature modular architecture with identical optical paths, uniform software, and a seamless user experience. The systems are designed with hardware-software co-design, incorporating volumetric imaging technology and Edge AI capabilities for real-time feature detection during scanning. The company was acquired by Evident (a scientific imaging company spun off from Olympus Corporation in 2022) in 2025.

Product and service4 records
1SpectralHT 4-Head
CategoryWhole Slide Imaging Scanner
Description

High-throughput autonomous whole slide imaging scanner with 4 scan heads providing redundancy and uninterrupted scanner availability. Supports up to 960 slides with 8 Pramana baskets, 480 slides with 4 Pramana baskets, or 320 slides with 16 Sakura baskets. Targeted at hospital and research laboratories with high-volume pathology scanning needs.

2SpectralHT 2-Head
CategoryWhole Slide Imaging Scanner
Description

High-throughput autonomous whole slide imaging scanner with 2 scan heads. Supports up to 480 slides with 4 Pramana baskets, 240 slides with 2 Pramana baskets, or 320 slides with 16 Sakura baskets. Designed for mid-volume laboratory needs with the same modular architecture as the 4-Head variant.

3SpectralM
CategoryWhole Slide Imaging Scanner
Description

Compact autonomous whole slide imaging scanner for lower-throughput needs. Supports 4 slides (1x3 inches) or 2 slides (2x3 inches). Targeted at smaller labs, satellite facilities, or specialty pathology practices needing autonomous scanning at a smaller scale.

4SpectralHT Cubiq
CategoryWhole Slide Imaging Scanner
Description

Modular variant of the SpectralHT scanner system designed for customized capacity configurations. Provides the same autonomous whole slide imaging capabilities as the standard SpectralHT in a configurable form factor.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-09-05
Description

EVIDENT and Siemens Healthineers joined efforts to advance digital pathology at Klinikum Ludwigshafen. Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Moffitt Cancer Center selected Evident's Pramana high-throughput scanning technology to expand digital pathology adoption and support clinical and research initiatives.

3nference
Strategic tierCoreTypeOthers
Description

Pramana was founded in 2021 by nference, a healthcare AI company, as a spin-off to commercialize digital pathology technology.

financialpost.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1KFBIO
TypeRegional player
Description

Chinese manufacturer of whole slide imaging scanners gaining share in Asia-Pacific. Regional peer with limited US/EU presence but direct hardware overlap.

TypeDirect peer
Description

Established manufacturer of whole slide imaging scanners (NanoZoomer series) widely deployed in clinical and research pathology. Direct hardware competitor with a much larger installed base and broader geographic reach.

TypeDirect peer
Description

Maker of Aperio whole slide imaging scanners and the larger Leica pathology workflow portfolio. Closest direct competitor with deep hospital pathology integration and a global clinical sales force.

TypeBroad incumbent
Description

Operates the Ventana DP200 and DP600 slide scanners as part of a much broader diagnostic and tissue diagnostics portfolio. Competes on integrated staining, scanning, and AI workflows.

TypeBroad incumbent
Description

Philips IntelliSite digital pathology solution combines WSI hardware with image management and analytics. Competes for large hospital network deployments where Philips' enterprise imaging footprint is a differentiator.

TypeDirect peer
Description

Hungarian vendor of P1000 and P250 whole slide imaging scanners with strong research and clinical adoption in Europe. Direct hardware peer with modular scanner designs similar in philosophy to Pramana's SpectralHT.

TypeEmerging player
Description

Cloud-native digital pathology software platform and a named IMS partner of Pramana. Also competes indirectly by offering software-centric pathology workflows that could substitute for hardware-led deployments.

TypeEmerging player
Description

AI pathology vendor focused on clinical-grade cancer detection from digitized slides. Competes at the analytics layer and could influence how labs evaluate scanner-and-AI bundle economics.

TypeEmerging player
Description

AI-pathology company offering diagnostic and drug-development pathology solutions. Competes on the AI/software layer that complements or substitutes for embedded scanner intelligence.

TypeEmerging player
Description

Provider of image analysis software (Halo) widely used in research pathology. Competes in downstream image analysis and could partner or compete with scanner-based AI pipelines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pramana

Digital Pathology Imaging Systemspramana.ai

Pramana, Inc. manufactures autonomous whole slide imaging scanners (SpectralHT, SpectralM) for digital pathology, serving hospitals, research facilities, and educational institutions. Founded in 2021 and acquired by Evident in 2025, the company operates from Cambridge, MA with proprietary volumetric imaging and edge AI capabilities.

What Pramana does

Pramana, Inc. is a Cambridge, Massachusetts-based medical technology company that designs and manufactures autonomous whole slide imaging (WSI) systems for digital pathology. Founded in 2021 as a spin-off from healthcare AI company nference, Pramana serves hospital pathology departments, research facilities, and educational institutions seeking to digitize and automate slide scanning workflows. The company has a workforce of 101–250 employees and operates as a wholly-owned subsidiary of Evident (the scientific imaging business spun off from Olympus Corporation in 2022) following its acquisition in August 2025.

Pramana's core product line is the Spectral family of scanners, which includes the high-throughput SpectralHT (available in 2-Head and 4-Head configurations supporting up to 960 slides), the compact SpectralM (supporting 2–4 slides per load), and the modular SpectralHT Cubiq. The systems are differentiated by hardware-software co-design, proprietary volumetric imaging that replicates optical microscope fine-focus through Z-stack fusion, and edge AI capable of executing multiple feature description algorithms in real time during scanning. The company holds four granted US patents and one pending application covering slide imaging, hot-swapping components, color gamut normalization, and inline image scan enrichment. Regulatory clearances include CE, EU IVDR, ISO 13485, and Health Canada Medical Device Licenses (granted July 2025); in the US, products are currently marketed for research use only.

Pramana generates revenue primarily through hardware sales of its integrated scanner systems, sold via enterprise field sales directly to healthcare and research customers. Named customers include Mayo Clinic, Duke, Moffitt Cancer Center, Caris Life Sciences, Iron Mountain, Arup, PRISMIC, and Splice Histology. Post-acquisition, distribution is augmented by Evident's global scientific imaging network. The company has established interoperability partnerships with image management system vendors including Proscia, GSTALT, pathPresenter, Techcyte, and Corista, and in September 2025 entered a strategic collaboration with Siemens Healthineers to advance digital pathology at Klinikum Ludwigshafen in Germany.

Pramana firmographics

Firmographics
Name
Pramana
Legal name
Pramana, Inc.
Website
https://pramana.ai
Company type
Private
Founded year
2021
Operating status
Acquired
Headcount range
51–100 employees
Short description
Pramana, Inc. manufactures autonomous whole slide imaging scanners (SpectralHT, SpectralM) for digital pathology, serving hospitals, research facilities, and educational institutions. Founded in 2021 and acquired by Evident in 2025, the company operates from Cambridge, MA with proprietary volumetric imaging and edge AI capabilities.
Ownership category
akta.pro rank

Pramana industry classification

Industry
Product category
Digital Pathology Imaging Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Digital pathology scanners
  • Whole slide imaging
  • Autonomous microscopy systems
  • Pathology imaging hardware
  • Clinical diagnostics equipment

Where Pramana is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Pramana business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Whole Slide Imaging Systems: Sale of autonomous whole slide imaging systems (SpectralHT, SpectralM) to hospitals, research facilities, and educational institutions. Hardware-software integrated solutions with modular configurations.
  2. AI-Powered Scanning Technologies: Sale of AI-powered scanning technologies and digital pathology solutions, including real-time feature detection and classification algorithms

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Pramana product offering

Product offering

Core offering

Pramana designs, manufactures, and sells autonomous whole slide imaging (WSI) scanners for digital pathology applications. Its Spectral family of scanners uses proprietary volumetric imaging and real-time edge AI to scan pathology slides without manual intervention, supporting clinical diagnostics, research, and educational use at hospitals, research facilities, and academic institutions.

Product overview

Pramana offers a portfolio of autonomous whole slide imaging systems for digital pathology under the Spectral family brand. The product line includes the SpectralHT (available in 2-Head and 4-Head configurations) for high-throughput laboratory needs, and the SpectralM for compact deployments. All systems feature modular architecture with identical optical paths, uniform software, and a seamless user experience. The systems are designed with hardware-software co-design, incorporating volumetric imaging technology and Edge AI capabilities for real-time feature detection during scanning. The company was acquired by Evident (a scientific imaging company spun off from Olympus Corporation in 2022) in 2025.

Differentiator

Problem solved

Functional benefit

Products and services

  • SpectralHT 4-Head High-throughput autonomous whole slide imaging scanner with 4 scan heads providing redundancy and uninterrupted scanner availability. Supports up to 960 slides with 8 Pramana baskets, 480 slides with 4 Pramana baskets, or 320 slides with 16 Sakura baskets. Targeted at hospital and research laboratories with high-volume pathology scanning needs.
  • SpectralHT 2-Head High-throughput autonomous whole slide imaging scanner with 2 scan heads. Supports up to 480 slides with 4 Pramana baskets, 240 slides with 2 Pramana baskets, or 320 slides with 16 Sakura baskets. Designed for mid-volume laboratory needs with the same modular architecture as the 4-Head variant.
  • SpectralM Compact autonomous whole slide imaging scanner for lower-throughput needs. Supports 4 slides (1x3 inches) or 2 slides (2x3 inches). Targeted at smaller labs, satellite facilities, or specialty pathology practices needing autonomous scanning at a smaller scale.
  • SpectralHT Cubiq Modular variant of the SpectralHT scanner system designed for customized capacity configurations. Provides the same autonomous whole slide imaging capabilities as the standard SpectralHT in a configurable form factor.

Quantifiable outcome

  • 70% reduction in manual workflow steps
  • +3 more outcomes

Companies that use Pramana

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Pramana technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature6 records

Pramana partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered major and core.

  • Siemens HealthineersmajorStrategic or Co-development Partner · 5 September 2025EVIDENT and Siemens Healthineers joined efforts to advance digital pathology at Klinikum Ludwigshafen. Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward.
  • Moffitt Cancer CentermajorStrategic or Co-development PartnerMoffitt Cancer Center selected Evident's Pramana high-throughput scanning technology to expand digital pathology adoption and support clinical and research initiatives.
  • nferencecoreOthersPramana was founded in 2021 by nference, a healthcare AI company, as a spin-off to commercialize digital pathology technology.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Pramana competitors and assessment

Company assessment

Regional players

  • KFBIO: Chinese manufacturer of whole slide imaging scanners gaining share in Asia-Pacific. Regional peer with limited US/EU presence but direct hardware overlap.

Direct peers

  • Hamamatsu Photonics: Established manufacturer of whole slide imaging scanners (NanoZoomer series) widely deployed in clinical and research pathology. Direct hardware competitor with a much larger installed base and broader geographic reach.
  • Leica Biosystems (Danaher): Maker of Aperio whole slide imaging scanners and the larger Leica pathology workflow portfolio. Closest direct competitor with deep hospital pathology integration and a global clinical sales force.
  • 3DHistech: Hungarian vendor of P1000 and P250 whole slide imaging scanners with strong research and clinical adoption in Europe. Direct hardware peer with modular scanner designs similar in philosophy to Pramana's SpectralHT.

Broad incumbents

  • Roche (Ventana): Operates the Ventana DP200 and DP600 slide scanners as part of a much broader diagnostic and tissue diagnostics portfolio. Competes on integrated staining, scanning, and AI workflows.
  • Philips (IntelliSite Pathology): Philips IntelliSite digital pathology solution combines WSI hardware with image management and analytics. Competes for large hospital network deployments where Philips' enterprise imaging footprint is a differentiator.

Emerging players

  • Proscia: Cloud-native digital pathology software platform and a named IMS partner of Pramana. Also competes indirectly by offering software-centric pathology workflows that could substitute for hardware-led deployments.
  • Ibex Medical Analytics: AI pathology vendor focused on clinical-grade cancer detection from digitized slides. Competes at the analytics layer and could influence how labs evaluate scanner-and-AI bundle economics.
  • PathAI: AI-pathology company offering diagnostic and drug-development pathology solutions. Competes on the AI/software layer that complements or substitutes for embedded scanner intelligence.
  • Indica Labs: Provider of image analysis software (Halo) widely used in research pathology. Competes in downstream image analysis and could partner or compete with scanner-based AI pipelines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Pramana social profiles

Digital presence

Pramana compliance and trust

Trust signal

Compliance3 records

Pramana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pramana leadership team

Management profile

Number of profiles

Profiles2 records

Pramana funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pramana M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pramana

What does Pramana do?

Pramana designs, manufactures, and sells autonomous whole slide imaging (WSI) scanners for digital pathology applications. Its Spectral family of scanners uses proprietary volumetric imaging and real-time edge AI to scan pathology slides without manual intervention, supporting clinical diagnostics, research, and educational use at hospitals, research facilities, and academic institutions.

Is Pramana a public or private company?

Pramana is a private company. It is classified as corporate owned and is currently acquired.

When was Pramana founded?

Pramana was founded in 2021. It employs 51 to 100 people.

Where is Pramana based?

Pramana is headquartered in Cambridge, United States, in the North America region.

How does Pramana make money?

Two revenue lines are on record. Whole Slide Imaging Systems are the primary driver. The others are AI-Powered Scanning Technologies.

Who are Pramana's main competitors?

KFBIO is listed as a regional player. Direct peers are Hamamatsu Photonics, Leica Biosystems (Danaher) and 3DHistech. Broad incumbents are Roche (Ventana) and Philips (IntelliSite Pathology). Emerging players are Proscia, Ibex Medical Analytics, PathAI and Indica Labs.

Does Pramana have an API?

No public API is recorded for Pramana.

What industry is Pramana in?

Pramana's product category is Digital Pathology Imaging Systems. Its primary akta.pro industry code is HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InderesInderesSwiss pharmaceutical company Roche announced the acquisition of US-based PathAI for up to $1.05 billion (including $750 million in cash and up to $300 million in milestone payments), marking a significant consolidation move in the digital pathology market. The deal represents the latest in a series of strategic acquisitions across the sector in 2025–2026, including Tempus AI acquiring Paige, AstraZeneca acquiring Modella AI, and Evident acquiring Pramana, reflecting heightened M&A activity in AI-powered pathology solutions. Analysts highlight Finnish company Aiforia as a potential acquisition target due to its broad portfolio of CE-IVDR certified AI algorithms and strong market position in AI-powered pathology image analysis.Pulse 2.0Evident Finalizes Acquisition Of Pramana To Advance Next Generation Digital PathologyEvident has completed its acquisition of Pramana, Inc., a provider of autonomous whole slide imaging systems for digital pathology. This transaction is intended to strengthen Evident’s position in the global digital pathology market and enhance its capabilities for digital imaging and diagnostics. The acquisition supports a trend towards digital diagnostic solutions among healthcare providers and research institutions.EvidentscientificEVIDENT Finalizes Acquisition of Pramana, Inc.Evident announced the completion of its acquisition of Pramana, Inc., a manufacturer of digital pathology solutions, on August 27, 2025. This acquisition aims to enhance Evident's product offerings and leverage Pramana’s advanced imaging technologies to improve digital pathology workflows. The combination is expected to accelerate the global adoption of digital pathology and facilitate the integration of AI-driven imaging systems into hospital and research settings.Photonics SpectraEvident Acquires Pramana for Autonomous ImagingEvident, the scientific imaging company spun off from Olympus Corporation in 2022, has agreed to acquire Pramana, a manufacturer of whole slide imaging technologies and digital pathology solutions founded in 2021. Pramana's autonomous scanning systems use volumetric imaging and real-time AI algorithms that the company claims can eliminate up to 70% of manual workflow steps while capturing previously undetectable tissue features. The acquisition will expand Evident's portfolio of AI-driven imaging technologies for hospitals, research facilities, and educational institutions, though deal terms were not disclosed.Financial PostEVIDENT to Acquire Pramana, Inc.Evident has announced a definitive agreement to acquire Pramana, Inc., a healthcare technology company specializing in autonomous whole slide imaging systems for digital pathology applications in hospitals, research facilities, and educational institutions. Founded in 2021 by nference, Pramana's AI-powered scanning technologies complement Evident's existing clinical microscopy and optics portfolio, enabling the combined entity to offer an expanded range of digital pathology solutions. The acquisition aims to accelerate global adoption of digital pathology and usher in what the companies describe as "digital pathology 2.0."GlobeNewswireEVIDENT to Acquire Pramana, Inc.Evident announced a definitive agreement to acquire Pramana, a manufacturer of digital pathology solutions. Pramana's autonomous whole slide imaging systems, combined with Evident's optics, aim to accelerate digital pathology adoption. The deal is expected to expand Evident's digital pathology product offering.GlobeNewswireEVIDENT to Acquire Pramana, Inc.Evident announced a definitive agreement to acquire Pramana, a manufacturer of digital pathology solutions. Pramana's autonomous whole slide imaging systems, combined with Evident's optics, aim to accelerate digital pathology adoption. The acquisition is expected to expand Evident's digital pathology product offering.InvestorshangoutEvident's Strategic Acquisition of Pramana: A Game ChangerEvident has announced its acquisition of Pramana, Inc., a digital pathology company founded in 2021 that specializes in autonomous image scanning systems with real-time AI algorithms for pathology workflows. The merger combines Evident's century-long expertise in clinical microscopy with Pramana's innovative imaging technologies, positioning the company to expand its offerings in the growing digital pathology market. The acquisition is expected to enhance diagnostic accuracy and operational efficiency for laboratories by integrating Evident's optical precision with Pramana's AI-driven analytics capabilities.Business & FinancialTechcyte, Pramana, And Aiosyn Collaborate To Advance Digital Pathology Workflow With Edge AI TechnologyTechcyte, Pramana, and Aiosyn announced a collaboration to integrate AI-powered breast and kidney histopathology analysis into digital pathology workflows. The integration uses Pramana's Edge AI and Aiosyn's IVDR-certified algorithms, with results displayed via DICOM annotations in Techcyte's Fusion platform.Business Wire BlogSpectrum Healthcare Partners Leverages Pramana’s AI-Enabled Scanners to Bring Digital Pathology to Central Maine HealthcareCentral Maine Healthcare, with Spectrum Healthcare Partners, will adopt Pramana's AI-enabled SpectralHT scanners to provide digital pathology services. The collaboration makes CMH the first hospital in Maine to implement digital pathology, aiming to improve diagnostic accuracy and reduce operational burdens.